Pimvanserin is used in the treatment of
**Core Concept**
Pimavanserin is a selective serotonin inverse agonist (SSIA) that targets the 5-HT2A receptor subtype. It is used in the treatment of a specific neuropsychiatric disorder characterized by hallucinations, delusions, and cognitive decline.
**Why the Correct Answer is Right**
Pimavanserin works by reducing the activity of the 5-HT2A receptor, which is involved in the regulation of dopamine release in the mesolimbic pathway. This pathway is implicated in the pathophysiology of psychosis in Parkinson's disease. By reducing dopamine release, pimavanserin helps to alleviate hallucinations and delusions in patients with Parkinson's disease.
**Why Each Wrong Option is Incorrect**
**Option A:** Although pimavanserin has a similar mechanism of action to antipsychotics, it is not a typical antipsychotic and is not used to treat schizophrenia or other psychiatric disorders.
**Option B:** Pimavanserin is not used to treat depression, anxiety, or other mood disorders.
**Option C:** Pimavanserin is not a dopamine agonist and is not used to treat symptoms of Parkinson's disease such as tremor or rigidity.
**Clinical Pearl / High-Yield Fact**
Pimavanserin is the first FDA-approved medication for the treatment of hallucinations and delusions in patients with Parkinson's disease. It is not a dopamine agonist and does not exacerbate motor symptoms in patients with Parkinson's disease.
**Correct Answer:** C. Pimavanserin is used in the treatment of hallucinations and delusions in patients with Parkinson's disease.